IL161710A0 - Macrolides - Google Patents

Macrolides

Info

Publication number
IL161710A0
IL161710A0 IL16171002A IL16171002A IL161710A0 IL 161710 A0 IL161710 A0 IL 161710A0 IL 16171002 A IL16171002 A IL 16171002A IL 16171002 A IL16171002 A IL 16171002A IL 161710 A0 IL161710 A0 IL 161710A0
Authority
IL
Israel
Prior art keywords
macrolides
Prior art date
Application number
IL16171002A
Other languages
English (en)
Original Assignee
Glaxo Group Ltd
Pliva Istrazivacki Inst D O O
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd, Pliva Istrazivacki Inst D O O filed Critical Glaxo Group Ltd
Publication of IL161710A0 publication Critical patent/IL161710A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
IL16171002A 2001-11-14 2002-11-13 Macrolides IL161710A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0127349.9A GB0127349D0 (en) 2001-11-14 2001-11-14 Macrolides
PCT/GB2002/005101 WO2003042228A1 (en) 2001-11-14 2002-11-13 Macrolides

Publications (1)

Publication Number Publication Date
IL161710A0 true IL161710A0 (en) 2004-09-27

Family

ID=9925777

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16171002A IL161710A0 (en) 2001-11-14 2002-11-13 Macrolides

Country Status (20)

Country Link
US (1) US7202221B2 (de)
EP (1) EP1453846B1 (de)
JP (1) JP2005515978A (de)
CN (1) CN1307194C (de)
AR (1) AR037371A1 (de)
AT (1) ATE362479T1 (de)
BR (1) BR0214132A (de)
CA (1) CA2466975A1 (de)
DE (1) DE60220180T2 (de)
EA (1) EA007433B1 (de)
ES (1) ES2287332T3 (de)
GB (1) GB0127349D0 (de)
HR (1) HRP20040433A2 (de)
HU (1) HUP0402225A3 (de)
IL (1) IL161710A0 (de)
PL (1) PL371472A1 (de)
RS (1) RS41904A (de)
UA (1) UA77210C2 (de)
WO (1) WO2003042228A1 (de)
ZA (1) ZA200403684B (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6995143B2 (en) * 2002-02-28 2006-02-07 Basilea Pharmaceutica Ag Macrolides with antibacterial activity
US7135573B2 (en) 2002-05-13 2006-11-14 Enanta Pharmaceuticals, Inc. Processes for the preparation of O-(6-Pyrazol-1-yl-pyridin-3-ylmethyl)-hydroxylamine
US6764998B1 (en) 2003-06-18 2004-07-20 Enanta Pharmaceuticals, Inc. 6,11-4C-bicyclic 9a-azalide derivatives
US7910558B2 (en) 2002-05-13 2011-03-22 Enanta Pharmaceuticals, Inc. Bridged macrocyclic compounds and processes for the preparation thereof
US7022679B2 (en) 2002-05-13 2006-04-04 Enanta Pharmaceuticals, Inc. Processes for the preparation of 6-11 bicyclic erythromycin derivatives
CN1652784A (zh) * 2002-05-14 2005-08-10 加利福尼亚大学董事会 取代的喹诺酮羧酸、它们的衍生物、作用部位、以及其用途
US7091196B2 (en) 2002-09-26 2006-08-15 Rib-X Pharmaceuticals, Inc. Bifunctional heterocyclic compounds and methods of making and using same
GB0225384D0 (en) * 2002-10-31 2002-12-11 Glaxo Group Ltd Novel compounds
US6645941B1 (en) 2003-03-26 2003-11-11 Enanta Pharmaceuticals, Inc. 6,11-3C-bicyclic 9a-azalide derivatives
GB0310980D0 (en) * 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds
GB0310979D0 (en) * 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds
CA2525455A1 (en) * 2003-05-13 2004-11-25 Glaxo Group Limited Novel 14 and 15 membered-ring compounds
GB0310986D0 (en) * 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds
GB0310984D0 (en) * 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds
WO2005030227A1 (en) 2003-09-23 2005-04-07 Enanta Pharmaceuticals, Inc. 9a, 11-3C-BICYCLIC 9a-AZALIDE DERIVATIVES
WO2005070113A2 (en) 2004-01-09 2005-08-04 Enanta Pharmaceuticals, Inc. 9n-substituted 6-11 bicyclic erythromycin derivatives
EP2716647A3 (de) 2004-02-27 2014-08-20 Rib-X Pharmaceuticals, Inc. Makrocyclische Verbindungen Und Verfahren Zu Deren Herstellung Und Anwendung
ATE439367T1 (de) * 2004-05-06 2009-08-15 Glaxosmithkline Zagreb Estergebundene makrolide, die sich für die behandlung von mikrobiellen infektionen eignen
US20080249033A1 (en) * 2004-05-06 2008-10-09 Sulejman Alihodzic Carbamate Linked Macrolides Useful For The Treatment Of Microbial Infections
WO2006047167A2 (en) * 2004-10-21 2006-05-04 Janssen Pharmaceutica, N.V. 9 alkyl and 9 alkylidenyl 6-0 alkyl-11, 12 carbamate ketolide antimicrobials
GB0424958D0 (en) * 2004-11-11 2004-12-15 Glaxo Group Ltd Novel compounds
GB0424951D0 (en) * 2004-11-11 2004-12-15 Glaxo Group Ltd Novel compounds
GB0424961D0 (en) * 2004-11-11 2004-12-15 Glaxo Group Ltd Novel compounds
GB0424959D0 (en) * 2004-11-11 2004-12-15 Glaxo Group Ltd Novel compounds
ES2428874T3 (es) * 2006-08-09 2013-11-12 Basilea Pharmaceutica Ag Nuevos macrólidos útiles contra las enfermedades inflamatorias y alérgicas
EP2056844A4 (de) 2006-08-24 2010-11-24 Wockhardt Research Center Neue makrolide und ketolide mit antimikrobieller wirkung
US8410065B2 (en) 2008-02-08 2013-04-02 Basilea Pharmaceutica Ag Macrolides and their use
CA2763246C (en) 2009-05-27 2013-10-29 Wockhardt Research Centre Ketolide compounds having antimicrobial activity
CA2820451C (en) 2010-12-09 2017-12-12 Wockhardt Limited Ketolide compounds
JPWO2012105562A1 (ja) * 2011-01-31 2014-07-03 Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 新規マクロライド誘導体
CN103619849B (zh) 2011-03-01 2016-05-25 沃克哈特有限公司 酮内酯中间体的制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0126344A2 (de) 1983-05-20 1984-11-28 Abbott Laboratories Tripeptidester von therapeutischen Mitteln
US4742049A (en) * 1986-06-04 1988-05-03 Abbott Laboratories Semisynthetic erythromycin antibiotics
JPH04504259A (ja) 1989-03-28 1992-07-30 アボツト・ラボラトリーズ エリスロマイシン誘導体
CA2064634C (en) * 1991-04-04 1998-08-04 James V. Heck 9-deoxo-8a-aza-8a-homoerythromycin a derivatives modified at the 4"- and8a-positions
IL126625A0 (en) 1996-05-07 1999-08-17 Abbott Lab 6-o-substituted erythromycin compounds and method for making same
EP0895999A1 (de) * 1997-08-06 1999-02-10 Pfizer Products Inc. C-4"-substituierte Macrolidantibiotica
US6262030B1 (en) * 1998-11-03 2001-07-17 Pfizer Inc. Erythromycin derivatives
AP2001002302A0 (en) 1999-05-24 2001-10-25 Pfizer Prod Inc 13-Methyl erythromycin derivatives.
EP1206476B1 (de) 1999-08-24 2006-01-04 Abbott Laboratories 9a-azalide mit antibakterieller wirkung
US6946446B2 (en) * 2000-02-24 2005-09-20 Abbott Laboratories Anti-infective agents useful against multidrug-resistant strains of bacteria
DK1259923T3 (da) 2000-02-24 2006-05-01 Abbott Lab Antiinfektionsmiddel, der er anvendeligt mod multilægemiddelresistente bakteriestammer
JP2002173498A (ja) 2000-09-27 2002-06-21 Hokuriku Seiyaku Co Ltd エリスロマイシン誘導体
GB0025688D0 (en) * 2000-10-19 2000-12-06 Glaxo Group Ltd Macrolides

Also Published As

Publication number Publication date
HUP0402225A2 (hu) 2005-02-28
CN1612888A (zh) 2005-05-04
AR037371A1 (es) 2004-11-03
BR0214132A (pt) 2004-09-14
CA2466975A1 (en) 2003-05-22
RS41904A (en) 2006-10-27
DE60220180T2 (de) 2008-01-17
EP1453846A1 (de) 2004-09-08
CN1307194C (zh) 2007-03-28
UA77210C2 (en) 2006-11-15
US20050080025A1 (en) 2005-04-14
DE60220180D1 (de) 2007-06-28
WO2003042228A1 (en) 2003-05-22
EA007433B1 (ru) 2006-10-27
GB0127349D0 (en) 2002-01-02
ATE362479T1 (de) 2007-06-15
US7202221B2 (en) 2007-04-10
ZA200403684B (en) 2005-09-13
JP2005515978A (ja) 2005-06-02
HUP0402225A3 (en) 2006-01-30
ES2287332T3 (es) 2007-12-16
EA200400536A1 (ru) 2004-12-30
PL371472A1 (en) 2005-06-13
HRP20040433A2 (en) 2005-04-30
EP1453846B1 (de) 2007-05-16

Similar Documents

Publication Publication Date Title
IL161710A0 (en) Macrolides
DE60213216D1 (en) Metalloproteinaseinhibitoren
IL157974A0 (en) Pesticidal macrolides
AU2002360430A8 (en) 14-methyl-epothilones
HU0400176V0 (en) Improved gasketseal
GB0108534D0 (en) Retaining means
AU2002313943A8 (en) Electromobile
GB0108110D0 (en) Keeps
GB0126277D0 (en) Macrolides
GB0127369D0 (en) Macrolides
GB0127352D0 (en) Macrolides
GB0127351D0 (en) Macrolides
GB0127345D0 (en) Macrolides
GB2376939B (en) Retaining means
AU2001100134A4 (en) Enviro-trap
GB0025687D0 (en) Macrolides
GB0025689D0 (en) Macrolides
GB0031314D0 (en) Macrolides
GB0031306D0 (en) Macrolides
GB0031313D0 (en) Macrolides
GB0031309D0 (en) Macrolides
GB0025691D0 (en) Macrolides
GB0031311D0 (en) Macrolides
GB0025683D0 (en) Macrolides
GB0025685D0 (en) Macrolides